Table 3.
Outcome | Experimental Condition | P-value | |
---|---|---|---|
Non-narrative | Narrative | ||
Post-exposure perceptions of social distancing effectiveness | 6.28 (.02) | 6.29 (.02) | .778 |
Post-exposure intentions to socially distance | 6.36 (.03) | 6.34 (.03) | .563 |
Post-exposure perceptions of vaccine safety and effectiveness | 5.96 (.02) | 6.00 (.02) | .174 |
Post-exposure intentions to receive a vaccine | 4.91 (.02) | 4.96 (.03) | .199 |
Post-exposure perceptions about the benefits of unproven drugs | 3.77 (.05) | 3.60 (.05) | .007 |
Post-exposure perceptions of importance of clinical trials | 6.25 (.03) | 6.29 (.03) | .289 |
Post-exposure intentions to receive an experimental drug | 3.77 (.04) | 3.46 (.04) | <.001 |